Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial managementK. Bushby, Carolyn M. Constantin, Richard S. Finkel et al.|The Lancet Neurology|2009Cited by 2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary careK. Bushby, Carolyn M. Constantin, Richard S. Finkel et al.|The Lancet Neurology|2009Cited by 1.2k
Agalsidase-Beta Therapy for Advanced Fabry DiseaseMaryam Banikazemi, Robert J. Desnick, Jan Bultas et al.|Annals of Internal Medicine|2007Cited by 565
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY ChallengeCatherine A. Brownstein, Claudia Gugenmus, Alan H. Beggs et al.|Genome biology|2014Cited by 432
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysisVera Fridman, Michael E. Shy, Brian N. Bundy et al.|Journal of Neurology Neurosurgery & Psychiatry|2014Cited by 342